NCT06629987已完成不适用
Determining the Most Efficient Screening Cut Off Levels for Phenylketonuria (PKU) by Assessing Two Years of Screening with Tandem Mass Spectrometry (MS) : a French National Cohort Study
Central Hospital, Nancy, France1 个研究点 分布在 1 个国家目标入组 360 人开始时间: 2021年1月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 360
- 试验地点
- 1
- 主要终点
- developping an PKU: id phenylanine over 360µmol/L
研究概览
简要总结
studying the screening of PKU in france with the new tandemMS
详细描述
Nationwide cohort study of the new pku screening for patient beetwen 180 and 360 µmol/L.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Other
入排标准
- 年龄范围
- 3 Days 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •having screening in france
排除标准
- •refusing neonatal screening
结局指标
主要结局
developping an PKU: id phenylanine over 360µmol/L
时间窗: 1 year
based on level of phenylalanine during the year of follow up
次要结局
- screening value(2 years)
研究者
HESS Valentin
MD, Principal Investigator
Central Hospital, Nancy, France
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Screening for Early Evidence of DiabetesDiabetes Mellitus, Type 2NCT00614783VeraLight, Inc.3,478
招募中
不适用
Optimising screening for early disease detection in familial pulmonary fibrosisNL-OMON51138Sint Antonius Ziekenhuis200
终止
不适用
Feasibility Study: Accuracy of Biomarker in Detection of Endometrial CancerUterine CancerEndometrial CancerNCT00471120Dick Domanik20
Unknown
1 期
A Study Comparing the Pharmacokinetic Similarity of MB02-SP, MB02-DM and USlicensed Avastin®.Healthy VolunteersNCT04408989mAbxience Research S.L.114
已完成
4 期
ACHIEVE: Optimizing the Treatment of Secondary HyperparathyroidismSecondary HyperparathyroidismNCT00135304Amgen170